Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
出版年份 2020 全文链接
标题
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-26
DOI
10.1038/s41380-020-00923-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- The transformative potential of plasma phosphorylated tau
- (2020) Clifford R Jack LANCET NEUROLOGY
- Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
- (2020) Antoine Leuzy et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
- (2020) Antoinette O’Connor et al. MOLECULAR PSYCHIATRY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Update on biomarkers for amyloid pathology in Alzheimer's disease
- (2018) Nicholas J Ashton et al. Biomarkers in Medicine
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- How Does the Accuracy of Intracranial Volume Measurements Affect Normalized Brain Volumes? Sample Size Estimates Based on 966 Subjects from the HUNT MRI Cohort
- (2015) T.I. Hansen et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Changes in Amyloid- and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
- (2013) L. F. Maia et al. Science Translational Medicine
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- FreeSurfer
- (2012) Bruce Fischl NEUROIMAGE
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
- (2009) Susan M. Landau et al. NEUROBIOLOGY OF AGING
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started